Logo

Artificial Intelligence: what do I need to know?


This event is aimed at business people eager to learn more about Artificial Intelligence (AI) and how it will impact their job and life. Many of us have heard of AI and are curious about it, but do not yet understand how it will impact our lives, both professionally and personally.
When: March 21, 2019, 9:00 AM – 4:30 PM CET

Where: Microsoft Brussels, 1K, Brussels National Airport – Brussels, Belgium

Meet CEO and Founder of Innoplexus at the artificial intelligence conference



Gunjan Bhardwaj
Innoplexus CEO



Agenda:


(9:00 am) – Registration
(9:25 am) – Welcome
(9:30 am) – Julie Foulon, MolenGeek Founder -The social ecosystem to make AI accessible to everyone
(10:00 am) – Ruben Audenaert, KBC AI and Data Analytics – Critical success factors for your AI implementation
(10:30 am) – Susana Zoghbi, Macty.eu CEO – AI in the fashion industry
(11:00 am) – COFFEE BREAK
(11:30 am) – Dr. Gunjan Bhardwaj, Innoplexus CEO – AI in healthcare – beyond the hype
(12:00 pm) – Jo Buvens, Salesforce Country Leader Belux – AI for a personalised customer experience.
(12:30 pm) – Lunch break
(13:30 pm) – Johan Loeckx, VUB Artificial Intelligence Lab – AI unraveled, but the mystery remains
(14:00 pm) – Ron Peeters, Technology Advisor Microsoft – What’s currently happening in AI?
(14:30 pm) – Thierry Geerts, Google Country Director Belgium – The impact of AI on society (plus discussion and Q&A)
(15:30 pm) – Bruno Schroder, Technology Officer of Microsoft BeLux – What developments to expect in the next two years
(16:00 pm) – Networking drink with demos in the Microsoft Technology Centre

The original event was published on learnai.live.
speaker-icon
What’s New in Ontosight® Terminal 1 . 1

What’s New in Ontosight® Terminal 1 . 1

Read more
Partex Accelerates Antibody Engineering for Neurodegenerative Diseases Using NVIDIA-Accelerated AI / ML Platform

Partex Accelerates Antibody Engineering for Neurodegenerative Diseases Using NVIDIA-Accelerated AI / ML Platform

Read more
Partex and Ark Biopharmaceutical Expand Strategic Collaboration with New Out-Licensing Agreement for ATR Inhibitor AK0658

Partex and Ark Biopharmaceutical Expand Strategic Collaboration with New Out-Licensing Agreement for ATR Inhibitor AK0658

Read more
award

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More
ontosight ad illustration

Ontosight®

FREE for a limited time

Try now

We use first-party cookies to provide you the best possible experience. Necessary By clicking "Accept", you agree to the use of our cookies on your device.